SCHEMBL6707760

SCHEMBL6707760

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)Cc4cccc(Cl)c4)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 2/20 0.41
LMNA P02545 2/20 0.37
POLB P06746 1/20 0.37
KCNQ2 O43526 4/20 0.36
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
CSNK1D P48730 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTK2B Q14289 1/20 0.34
RORC P51449 2/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
ROCK2 O75116 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712091 0.93 PARP14 (0.39) PARP14LMNAPOLBMEN1KMT2A
SCHEMBL6711927 0.92 PARP14 (0.44) PARP14LMNAPOLBRORC
SCHEMBL6711435 0.92 PARP14 (0.42) PARP14LMNAPOLBKCNQ2CSNK1D
SCHEMBL6712041 0.92 LMNA (0.41) PARP14LMNAPOLBKCNQ2CSNK1D
SCHEMBL6710203 0.91 PARP14 (0.41) PARP14LMNAPOLBKCNQ2MAPK8
SCHEMBL6713522 0.91 PARP14 (0.41) PARP14LMNAPOLBKCNQ2RORC
SCHEMBL6708920 0.90 PARP14 (0.42) PARP14LMNAPOLBMAPK8MEN1
SCHEMBL6916001 0.90 PARP14 (0.42) PARP14LMNAPOLBMEN1KMT2A
SCHEMBL6707786 0.90 GALR3 (0.36) PARP14LMNAPOLBMEN1KMT2A
SCHEMBL6713271 0.89 PARP14 (0.36) PARP14LMNAPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885LMNA 4062/4885POLB 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.